| Food preferences in human obesity: carbohydrates versus fats A Drewnowski, C Kurth, J Holden-Wiltse, J Saari Appetite 18 (3), 207-221, 1992 | 396 | 1992 |
| Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus H Miao, JA Hollenbaugh, MS Zand, J Holden-Wiltse, TR Mosmann, ... Journal of virology 84 (13), 6687-6698, 2010 | 239 | 2010 |
| Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial JJ Treanor, GM Schiff, FG Hayden, RC Brady, CM Hay, AL Meyer, ... Jama 297 (14), 1577-1582, 2007 | 222 | 2007 |
| Simulation and prediction of the adaptive immune response to influenza A virus infection HY Lee, DJ Topham, SY Park, J Hollenbaugh, J Treanor, TR Mosmann, ... Journal of virology 83 (14), 7151-7165, 2009 | 221 | 2009 |
| Phase I studies of hypericin, the active compound in St. John's wort, as an antiretroviral agent in HIV-infected adults: AIDS clinical trials group protocols 150 and 258 RM Gulick, V McAuliffe, J Holden-Wiltse, C Crumpacker, L Liebes, ... Annals of internal medicine 130 (6), 510-514, 1999 | 197 | 1999 |
| Clinical characterization and prediction of clinical severity of SARS-CoV-2 infection among US adults using data from the US National COVID Cohort Collaborative TD Bennett, RA Moffitt, JG Hajagos, B Amor, A Anand, MM Bissell, ... JAMA network open 4 (7), e2116901-e2116901, 2021 | 185 | 2021 |
| Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team. BJ Dezube, JH Von Roenn, J Holden-Wiltse, TW Cheung, SC Remick, ... Journal of clinical oncology 16 (4), 1444-1449, 1998 | 151 | 1998 |
| Influenza virus vaccination elicits poorly adapted B cell responses in elderly individuals C Henry, NY Zheng, M Huang, A Cabanov, KT Rojas, K Kaur, SF Andrews, ... Cell Host & Microbe 25 (3), 357-366. e6, 2019 | 145 | 2019 |
| Impact of prematurity and nutrition on the developing gut microbiome and preterm infant growth A Grier, X Qiu, S Bandyopadhyay, J Holden-Wiltse, HA Kessler, AL Gill, ... Microbiome 5, 1-19, 2017 | 128 | 2017 |
| Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine … LM Demeter, RW Shafer, PM Meehan, J Holden-Wiltse, MA Fischl, ... Antimicrobial agents and chemotherapy 44 (3), 794-797, 2000 | 119 | 2000 |
| Neonatal gut and respiratory microbiota: coordinated development through time and space A Grier, A McDavid, B Wang, X Qiu, J Java, S Bandyopadhyay, H Yang, ... Microbiome 6, 1-19, 2018 | 85 | 2018 |
| High-resolution temporal response patterns to influenza vaccine reveal a distinct human plasma cell gene signature AD Henn, S Wu, X Qiu, M Ruda, M Stover, H Yang, Z Liu, SL Welle, ... Scientific reports 3 (1), 2327, 2013 | 76 | 2013 |
| Taste responses and food preferences in obese women: effects of weight cycling. A Drewnowski, J Holden-Wiltse International Journal of Obesity and Related Metabolic Disorders: Journal of …, 1992 | 72 | 1992 |
| Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS JM Jacobson, R Hafner, J Remington, C Farthing, J Holden-Wiltse, ... Aids 15 (5), 583-589, 2001 | 69 | 2001 |
| Transcriptomic biomarkers to discriminate bacterial from nonbacterial infection in adults hospitalized with respiratory illness S Bhattacharya, AF Rosenberg, DR Peterson, K Grzesik, AM Baran, ... Scientific reports 7 (1), 6548, 2017 | 61 | 2017 |
| A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease AJ Japour, JJ Lertora, PM Meehan, A Erice, JD Connor, BP Griffith, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 13 (3), 235-246, 1996 | 58 | 1996 |
| Modeling of influenza-specific CD8+ T cells during the primary response indicates that the spleen is a major source of effectors H Wu, A Kumar, H Miao, J Holden-Wiltse, TR Mosmann, AM Livingstone, ... The Journal of Immunology 187 (9), 4474-4482, 2011 | 51 | 2011 |
| Microbiome-transcriptome interactions related to severity of respiratory syncytial virus infection AR Sonawane, L Tian, CY Chu, X Qiu, L Wang, J Holden-Wiltse, A Grier, ... Scientific reports 9 (1), 13824, 2019 | 46 | 2019 |
| Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151 MA Fischl, DD Richman, C Flexner, MF Para, R Haubrich, A Karim, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 15 (1), 28-34, 1997 | 45 | 1997 |
| Development of a global respiratory severity score for respiratory syncytial virus infection in infants MT Caserta, X Qiu, B Tesini, L Wang, A Murphy, A Corbett, DJ Topham, ... The Journal of infectious diseases 215 (5), 750-756, 2017 | 43 | 2017 |
